From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe

References

• Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, et al. Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 2005; 16(2)198–202
   PubMed Web of Science ®Google Scholar
• Bargagli AM, Sperati A, Davoli M, Forastiere F, Perucci CA. Mortality among problem drug users in Rome: An 18-year follow-up study, 1980–97. Addiction 2001; 96: 1455–1463
   PubMed Web of Science ®Google Scholar
• Bergeron H, Kopp P. Policy paradigms, ideas, and interests: The case of the French Public Health Policy toward drug abuse. The ANNALS of the American Academy of Political and Social Science 2002; 582(1)37–48
   Google Scholar
• Best D, Campbell A. The NTA's 2006 National Prescribing Audit. An assessment of prescribing practices for opioid substitution treatment in England, 2004–05. The National Treatment Agency for Substance Misuse (NTA), LondonUK 2007, (Available at: http://www.nta.nhs.uk/publications/documents/nta_npa1_prescribing_audit.pdf. Date last accessed 22/2/08)
   Google Scholar
• Commission of the European Communities (COM). Communication from the Commission to the Council and the European Parliament on the results of the final evaluation of the EU drugs strategy and action plan on drugs (2000–2004). 2004, (Available at: http://eur-lex.europa.eu/LexUriServ/site/en/com/2004/com2004_0707en01.pdf)
   Google Scholar
• Commission of the European Communities (COM). Report from the Commission to the European Parliament and the Council on the implementation of the Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence. 2007, (Available at: http://eur-lex.europa.eu/LexUriServ/site/en/com/2007/com2007_0199en01.pdf–date last accessed 22 February 2008)
   Google Scholar
• De la Fuente L, Brugal MT, Domingo-Salvany A, Bravo MJ, Neira-León M, Barrio G. Más de treinta años de drogas ilegales en España: una amarga historia con algunos consejos para el futuro [More than thirty years of illicit drugs in Spain: A bitter story with some messages for the future]. Revista Española de Salud Pública 2006; 80(5)505–520
   PubMedGoogle Scholar
• Diamandouros N. The European Ombudsman and EU drugs policy. ‘Drug addiction, treatment and prevention in a United Europe: Diversity and equality’. Speech at the 10th European Conference on Rehabilitation and Drug Policy. Hersonissos, Crete May, 2005, (Available at: http://ombudsman.europa.eu/speeches/en/2005-05-14.htm), 2005
   Google Scholar
• Dole VP, Nyswander ME. Medical treatment for diacetylmorphine (heroin) addiction. Journal of the American Medical Association 1965; 193: 646–650
   PubMed Web of Science ®Google Scholar
• EMCDDA. A European perspective on responding to blood borne infections among injecting drug users. A Short Briefing Paper prepared by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) at the request of the Horizontal Drugs Group of the Council of the European Union. 2004, (Available at: www.emcdda.europa.eu/html.cfm/index5777EN.html–date last accessed 22 February 2008)
   Google Scholar
• EMCDDA. Annual report 2005: The state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction, LisbonPortugal 2005
   Google Scholar
• EMCDDA. Annual report 2006: The state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction, LisbonPortugal 2006
   Google Scholar
• Emmanuelli J, Desenclos JC. Harm reduction interventions, behaviours and associated health outcomes in France, 1996–2003. Addiction 2005; 100(11)1690–1700
   PubMed Web of Science ®Google Scholar
• Estonian National Focal Point/National Institute for Health Development. National report on the drugs situation in Estonia. National Institute for Health Development publications, TallinnEstonia 2006
   Google Scholar
• Euro-HIV. The HIV epidemic associated with injecting drug use in Europe, 1985–1995. HIV/AIDS Surveillance in Europe June, 1996; 50, (Available at: http://www.eurohiv.org/reports/report_50/hiv_epidemic.pdf.–date last accessed 22 February 2008)
   Google Scholar
• Farrell F, Verster A, Davoli M, Nilson M, Merino PP. Reviewing current practice in drug-substitution treatment in the European Union. EMCDDA Insights Series, 3. EMCDDA publications, LisbonPortugal 2000
   Google Scholar
• Frischer M, Goldberg D, Rahman M, Berney L. Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1994. Addiction 1997; 92(4)419–427
   PubMed Web of Science ®Google Scholar
• Hartnoll R. Drug epidemiology in the European institutions: Historical background and key indicators. Bulletin on Narcotics 2003; 55(1–2)53–71
   Google Scholar
• Hartnoll R, Avico U, Ingold FR, Lange K, Lenke L, O’Hare A, et al. A multi-city study of drug misuse in Europe. Bulletin on Narcotics 1989; 41(1–2)3–27
   PubMedGoogle Scholar
• Kouvonen P, Skretting A, Rosenqvist P. Drugs in the Nordic and Baltic Countries. Common concerns, different realities. NAD, 48. Nordic Council for Alcohol and Drug Research publications, Helsinki 2006
   Google Scholar
• Kringsholm B, Kaa E, Steentoft A, Worm K, Simonsen KW. Deaths among drug addicts in Denmark in 1987–1991. Forensic Science International 1994; 10;67(3)185–195
   Web of Science ®Google Scholar
• Lepère B, Gourarier L, Sanchez M, Adda C, Peyret E, Nordmann F, et al. Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments. Annales de Médecine Interne 2001; 152(3)5–12
   Google Scholar
• Michels II, Stöver H, Gerlach R. Substitution treatment for opiate addicts in Germany. Harm Reduction Journal 2007; 4(5), (Available at: http://www.harmreductionjournal.com/content/pdf/1477-7517-4-5.pdf)
   PubMedGoogle Scholar
• Observatoire français des drogues et des toxicomanies (OFDT). Les traitements de substitution en France: résultats récents 2004. Tendances 2004; 37, (Available at: http://www.ofdt.fr/ofdtdev/live/publi/tend/tend37_fr.html)
   Google Scholar
• Strang J, Gossop M. Heroin addiction and the British system. Vol. 1: Origins and evolution. Routledge, New York 2005
   Google Scholar
• Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence 2003; 70(3)275–286
   PubMed Web of Science ®Google Scholar
• World Health Organization. The practices and context of pharmacotherapy of opioid dependence in Central and Eastern Europe. Department of Mental Health and Substance Abuse, document WHO/MSD/MSB/04.1., World Health Organization, GenevaSwitzerland 2004, (Available at: http://www.who.int/substance_abuse/publications/en/opioid_dependence_ceec.pdf.–date last accessed 22 February 2008)
   Google Scholar